How to manage severe hyponatremia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Severe Hyponatremia (Sodium 112 mEq/L)

For severe hyponatremia with sodium of 112 mEq/L, immediate treatment with 3% hypertonic saline is recommended to increase serum sodium by 4-6 mEq/L within 1-2 hours, with a maximum correction of 8 mEq/L in 24 hours to avoid osmotic demyelination syndrome. 1

Initial Assessment and Classification

First, determine the volume status and chronicity of hyponatremia:

  • Volume status assessment: Hypovolemic, euvolemic, or hypervolemic 2
  • Chronicity: Acute (<48 hours) or chronic (>48 hours) 2
  • Symptom severity: Mild (nausea, weakness), moderate (confusion), or severe (seizures, coma) 1, 3

Laboratory workup should include:

  • Serum osmolality, electrolytes, BUN, creatinine
  • Urine sodium, osmolality, specific gravity
  • Additional tests: CBC, liver function, TSH 1

Treatment Algorithm Based on Symptoms and Volume Status

1. Severe Symptomatic Hyponatremia (seizures, coma, respiratory distress)

  • Immediate intervention required:
    • Administer 3% hypertonic saline to increase serum sodium by 4-6 mEq/L within 1-2 hours 1
    • Initial bolus: 100-150 mL of 3% saline over 10-20 minutes, may repeat if symptoms persist 3
    • Monitor serum sodium every 2-4 hours initially 1
    • Maximum correction: 8 mEq/L in 24 hours to avoid osmotic demyelination syndrome 2, 1

2. Treatment Based on Volume Status

Hypovolemic Hyponatremia:

  • Discontinue diuretics/laxatives 2
  • Fluid resuscitation: 0.9% normal saline or 5% IV albumin 2
  • Monitor: Serum sodium every 4-6 hours until stable 1

Euvolemic Hyponatremia:

  • Fluid restriction: 1000 mL/day 2, 1
  • Salt tablets: Consider oral supplementation (5-10 mmol/kg/day) 1
  • For refractory cases: Consider vasopressin antagonists (vaptans) for short-term use 2, 4

Hypervolemic Hyponatremia:

  • Fluid restriction: More severe restriction (<1000 mL/day) 2
  • Discontinue diuretics/laxatives that may be contributing 2
  • Albumin infusion: Particularly beneficial in cirrhosis with severe hyponatremia 2, 1
  • Treat underlying cause: Heart failure, cirrhosis, etc. 1

Special Considerations

Correction Rate

  • Standard correction rate: Maximum 8 mEq/L in 24 hours 2, 1
  • High-risk patients (alcoholism, malnutrition, liver disease): Consider slower correction (4-6 mEq/L in 24 hours) 2
  • Monitor closely: Check serum sodium every 2-4 hours during active correction 1

Osmotic Demyelination Syndrome (ODS) Prevention

  • Risk factors: Chronic hyponatremia, alcoholism, liver disease, malnutrition 2, 4
  • Warning signs: Dysarthria, dysphagia, altered mental status, quadriparesis 2
  • If overcorrection occurs: Consider administration of hypotonic fluids or desmopressin to re-lower sodium 1

Use of Vasopressin Antagonists (Vaptans)

  • Consider for: Euvolemic or hypervolemic hyponatremia refractory to conventional therapy 2, 4
  • Contraindicated in: Hypovolemic hyponatremia 1
  • Caution: Not recommended for long-term use in cirrhosis due to safety concerns 1, 4
  • Monitor: Risk of overly rapid correction and hypernatremia 4

Ongoing Management

  • Follow-up monitoring: Severe abnormalities require follow-up within 24-48 hours 1
  • Identify and address underlying cause: SIADH, medications, endocrine disorders 1, 3
  • Medication review: Assess for medications that can cause hyponatremia (diuretics, antidepressants, antipsychotics, antiepileptics) 1

Common Pitfalls to Avoid

  1. Overly rapid correction: Can lead to osmotic demyelination syndrome 2, 1
  2. Inadequate monitoring: Serum sodium must be checked frequently during correction 1
  3. Inappropriate fluid administration: Avoid hypotonic fluids in symptomatic hyponatremia 1
  4. Failure to identify underlying cause: Treatment should address the root cause 1, 3
  5. Using vaptans in hypovolemic patients: Can worsen volume depletion 1, 4

By following this structured approach based on symptom severity and volume status, severe hyponatremia can be managed effectively while minimizing the risk of complications.

References

Guideline

Management of Abnormal Sodium and Chloride Levels

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.